Mass media learned about a suspension the international pharmaceutical companies development to Russian Federation

Among them Pfizer, Inc, Johnson & Johnson Inc., AstraZeneca plc, Novartis Int AG and Janssen. They suspended clinical trials in our country and do not recruit volunteers for the current tests. Thus, in the next ten years patients to Russian Federation can not receive about 300 preparations developed by the international pharmaceutical companies. newspaper "Kommersant", referring to University research Sechenov's name. Experts made the forecast on the basis of a portfolio of development 20 largest holdings. Drugs on which the first phase of clinical trials is carried out at least were taken into account...